| Target and Pathway |
Top |
| Target(s) |
B lymphocyte kinase (BLK) |
Target Info
|
Inhibitor |
[1] |
| Janus kinase 1 (JAK-1) |
Target Info
|
Inhibitor |
[1] |
| Janus kinase 2 (JAK-2) |
Target Info
|
Inhibitor |
[1] |
| Janus kinase 3 (JAK-3) |
Target Info
|
Inhibitor |
[1] |
| T-cell-specific kinase (ITK) |
Target Info
|
Inhibitor |
[1] |
| TYK2 tyrosine kinase (TYK2) |
Target Info
|
Inhibitor |
[1] |
| Tyrosine-protein kinase BTK (ATK) |
Target Info
|
Inhibitor |
[1] |
| Tyrosine-protein kinase Tec (PSCTK4) |
Target Info
|
Inhibitor |
[1] |
| Target's Patent Info |
B lymphocyte kinase (BLK) |
Target's Patent Info
|
[1] |
| Janus kinase 1 (JAK-1) |
Target's Patent Info
|
[1] |
| Janus kinase 2 (JAK-2) |
Target's Patent Info
|
[1] |
| Janus kinase 3 (JAK-3) |
Target's Patent Info
|
[1] |
| T-cell-specific kinase (ITK) |
Target's Patent Info
|
[1] |
| TYK2 tyrosine kinase (TYK2) |
Target's Patent Info
|
[1] |
| Tyrosine-protein kinase BTK (ATK) |
Target's Patent Info
|
[1] |
| Tyrosine-protein kinase Tec (PSCTK4) |
Target's Patent Info
|
[1] |
|
KEGG Pathway
|
Chemokine signaling pathway
|
|
PI3K-Akt signaling pathway
|
|
Signaling pathways regulating pluripotency of stem cells
|
|
Jak-STAT signaling pathway
|
|
Cholinergic synapse
|
|
Prolactin signaling pathway
|
|
Adipocytokine signaling pathway
|
|
Leishmaniasis
|
|
Toxoplasmosis
|
|
Tuberculosis
|
|
Measles
|
|
Influenza A
|
|
Herpes simplex infection
|
|
Osteoclast differentiation
|
|
Hepatitis C
|
|
Hepatitis B
|
|
HTLV-I infection
|
|
Epstein-Barr virus infection
|
|
Pathways in cancer
|
|
Viral carcinogenesis
|
|
Pancreatic cancer
|
|
T cell receptor signaling pathway
|
|
Leukocyte transendothelial migration
|
|
NF-kappa B signaling pathway
|
|
Platelet activation
|
|
B cell receptor signaling pathway
|
|
Fc epsilon RI signaling pathway
|
|
Primary immunodeficiency
|
|
NetPath Pathway
|
IL2 Signaling Pathway
|
|
Panther Pathway
|
Inflammation mediated by chemokine and cytokine signaling pathway
|
|
Interferon-gamma signaling pathway
|
|
JAK/STAT signaling pathway
|
|
PDGF signaling pathway
|
|
PI3 kinase pathway
|
|
CCKR signaling map ST
|
|
Angiogenesis
|
|
B cell activation
|
|
Interleukin signaling pathway
|
|
Pathwhiz Pathway
|
Fc Epsilon Receptor I Signaling in Mast Cells
|
|
Pathway Interaction Database
|
Endothelins
|
|
ErbB4 signaling events
|
|
GMCSF-mediated signaling events
|
|
IL4-mediated signaling events
|
|
IL27-mediated signaling events
|
|
Signaling events mediated by PTP1B
|
|
IL12-mediated signaling events
|
|
S1P3 pathway
|
|
SHP2 signaling
|
|
CXCR4-mediated signaling events
|
|
IL5-mediated signaling events
|
|
IFN-gamma pathway
|
|
ErbB2/ErbB3 signaling events
|
|
IL3-mediated signaling events
|
|
IL6-mediated signaling events
|
|
PDGFR-beta signaling pathway
|
|
IL23-mediated signaling events
|
|
Signaling events mediated by Stem cell factor receptor (c-Kit)
|
|
EPO signaling pathway
|
|
Notch-mediated HES/HEY network
|
|
p73 transcription factor network
|
|
Signaling events mediated by TCPTP
|
|
IL2-mediated signaling events
|
|
IL2 signaling events mediated by PI3K
|
|
PDGFR-alpha signaling pathway
|
|
IL2 signaling events mediated by STAT5
|
|
Fc-epsilon receptor I signaling in mast cells
|
|
TCR signaling in naï
|
|
|
|
Class I PI3K signaling events
|
|
BCR signaling pathway
|
|
FAS (CD95) signaling pathway
|
|
CD40/CD40L signaling
|
|
Reactome
|
Interleukin-6 signaling
|
|
MAPK3 (ERK1) activation
|
|
MAPK1 (ERK2) activation
|
|
GPVI-mediated activation cascade
|
|
Prolactin receptor signaling
|
|
RMTs methylate histone arginines
|
|
G beta:gamma signalling through PI3Kgamma
|
|
Interleukin-3, 5 and GM-CSF signaling
|
|
RAF activation
|
|
RAF/MAP kinase cascade
|
|
Interferon gamma signaling
|
|
Regulation of IFNG signaling
|
|
Interleukin receptor SHC signaling
|
|
Growth hormone receptor signaling
|
|
Factors involved in megakaryocyte development and platelet production
|
|
ISG15 antiviral mechanism
|
|
Interleukin-7 signaling
|
|
Interleukin-2 signaling
|
|
Interferon alpha/beta signaling
|
|
Regulation of IFNA signaling
|
|
Generation of second messenger molecules
|
|
FCERI mediated Ca+2 mobilization
|
|
MyD88:Mal cascade initiated on plasma membrane
|
|
Regulation of actin dynamics for phagocytic cup formation
|
|
DAP12 signaling
|
|
MyD88 deficiency (TLR2/4)
|
|
IRAK4 deficiency (TLR2/4)
|
|
RHO GTPases Activate WASPs and WAVEs
|
|
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
|
WikiPathways
|
Serotonin Receptor 2 and STAT3 Signaling
|
|
Type II interferon signaling (IFNG)
|
|
Notch Signaling Pathway
|
|
EPO Receptor Signaling
|
|
EGF/EGFR Signaling Pathway
|
|
IL-4 Signaling Pathway
|
|
IL-6 signaling pathway
|
|
Kit receptor signaling pathway
|
|
IL-3 Signaling Pathway
|
|
Mesodermal Commitment Pathway
|
|
Interleukin-2 signaling
|
|
Signaling by SCF-KIT
|
|
Prolactin receptor signaling
|
|
Growth hormone receptor signaling
|
|
JAK/STAT
|
|
BDNF signaling pathway
|
|
Oncostatin M Signaling Pathway
|
|
Interleukin-11 Signaling Pathway
|
|
AGE/RAGE pathway
|
|
TSLP Signaling Pathway
|
|
IL17 signaling pathway
|
|
Leptin signaling pathway
|
|
TSH signaling pathway
|
|
Interleukin-3, 5 and GM-CSF signaling
|
|
Interferon gamma signaling
|
|
Factors involved in megakaryocyte development and platelet production
|
|
IL-5 Signaling Pathway
|
|
Interferon type I signaling pathways
|
|
TGF Beta Signaling Pathway
|
|
IL-2 Signaling Pathway
|
|
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
|
|
Interleukin-7 signaling
|
|
PDGF Pathway
|
|
Prostate Cancer
|
|
IL-9 Signaling Pathway
|
|
Type III interferon signaling
|
|
IL-7 Signaling Pathway
|
|
Integrated Breast Cancer Pathway
|
|
Integrated Cancer pathway
|
|
Interferon alpha/beta signaling
|
|
TCR Signaling Pathway
|
|
T-Cell Receptor and Co-stimulatory Signaling
|
|
TCR signaling
|
|
MyD88:Mal cascade initiated on plasma membrane
|
|
Signaling by the B Cell Receptor (BCR)
|
|
DAP12 interactions
|
|
B Cell Receptor Signaling Pathway
|
|
Regulation of toll-like receptor signaling pathway
|
